PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Name | miRBASE accession |
---|---|
mmu-miR-21a-5p
|
MIMAT0000530 |
mmu-miR-21c
|
MIMAT0025148 |
mmu-miR-590-5p
|
MIMAT0004895 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_64960705 | 6.13 |
ENSMUST00000165536.8
|
Klf3
|
Kruppel-like factor 3 (basic) |
chr2_-_136958544 | 5.50 |
ENSMUST00000028735.8
|
Jag1
|
jagged 1 |
chr13_+_56757389 | 5.43 |
ENSMUST00000045173.10
|
Tgfbi
|
transforming growth factor, beta induced |
chr3_-_131138541 | 4.38 |
ENSMUST00000090246.5
ENSMUST00000126569.2 |
Sgms2
|
sphingomyelin synthase 2 |
chr13_-_111945499 | 4.17 |
ENSMUST00000109267.9
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1 |
chr11_+_60822859 | 3.95 |
ENSMUST00000019076.10
|
Map2k3
|
mitogen-activated protein kinase kinase 3 |
chr4_-_3938352 | 3.88 |
ENSMUST00000003369.10
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr11_+_85723377 | 3.84 |
ENSMUST00000000095.7
|
Tbx2
|
T-box 2 |
chr15_+_85619958 | 3.40 |
ENSMUST00000109422.8
|
Ppara
|
peroxisome proliferator activated receptor alpha |
chr16_+_4412546 | 3.38 |
ENSMUST00000014447.13
|
Glis2
|
GLIS family zinc finger 2 |
chr15_-_73056713 | 3.31 |
ENSMUST00000044113.12
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr6_-_14755249 | 3.20 |
ENSMUST00000045096.6
|
Ppp1r3a
|
protein phosphatase 1, regulatory subunit 3A |
chr4_+_8691303 | 2.91 |
ENSMUST00000051558.10
|
Chd7
|
chromodomain helicase DNA binding protein 7 |
chr6_-_39183712 | 2.91 |
ENSMUST00000002305.9
|
Kdm7a
|
lysine (K)-specific demethylase 7A |
chr18_+_75500600 | 2.87 |
ENSMUST00000026999.10
|
Smad7
|
SMAD family member 7 |
chr13_-_101904662 | 2.86 |
ENSMUST00000055518.13
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1 |
chr3_+_60408600 | 2.63 |
ENSMUST00000099087.8
|
Mbnl1
|
muscleblind like splicing factor 1 |
chr4_+_97665843 | 2.63 |
ENSMUST00000075448.13
ENSMUST00000092532.13 |
Nfia
|
nuclear factor I/A |
chr19_+_6326755 | 2.57 |
ENSMUST00000025684.4
|
Ehd1
|
EH-domain containing 1 |
chr18_+_84106188 | 2.55 |
ENSMUST00000060223.4
|
Zadh2
|
zinc binding alcohol dehydrogenase, domain containing 2 |
chr5_+_52521133 | 2.50 |
ENSMUST00000101208.6
|
Sod3
|
superoxide dismutase 3, extracellular |
chr11_+_21041291 | 2.46 |
ENSMUST00000093290.12
|
Peli1
|
pellino 1 |
chr9_-_8004586 | 2.43 |
ENSMUST00000086580.12
ENSMUST00000065353.13 |
Yap1
|
yes-associated protein 1 |
chr1_-_74163575 | 2.43 |
ENSMUST00000169786.8
ENSMUST00000212888.2 ENSMUST00000191104.7 |
Tns1
|
tensin 1 |
chr2_-_104324745 | 2.31 |
ENSMUST00000028600.14
|
Hipk3
|
homeodomain interacting protein kinase 3 |
chr11_+_60308077 | 2.29 |
ENSMUST00000070681.7
|
Gid4
|
GID complex subunit 4, VID24 homolog |
chr5_+_102629240 | 2.27 |
ENSMUST00000073302.12
ENSMUST00000094559.9 |
Arhgap24
|
Rho GTPase activating protein 24 |
chr4_-_19708910 | 2.25 |
ENSMUST00000108246.9
|
Wwp1
|
WW domain containing E3 ubiquitin protein ligase 1 |
chr5_-_136596299 | 2.24 |
ENSMUST00000004097.16
|
Cux1
|
cut-like homeobox 1 |
chr10_+_86136236 | 2.18 |
ENSMUST00000020234.14
|
Timp3
|
tissue inhibitor of metalloproteinase 3 |
chrX_+_41238193 | 2.14 |
ENSMUST00000115073.9
ENSMUST00000115072.8 |
Stag2
|
stromal antigen 2 |
chr14_+_64181115 | 2.10 |
ENSMUST00000079652.7
|
Sox7
|
SRY (sex determining region Y)-box 7 |
chr10_-_61288437 | 2.01 |
ENSMUST00000167087.2
ENSMUST00000020288.15 |
Eif4ebp2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr9_-_85209162 | 1.89 |
ENSMUST00000034802.15
|
Tent5a
|
terminal nucleotidyltransferase 5A |
chr1_-_134006847 | 1.80 |
ENSMUST00000020692.7
|
Btg2
|
BTG anti-proliferation factor 2 |
chr4_-_155306992 | 1.74 |
ENSMUST00000084103.10
ENSMUST00000030917.6 |
Ski
|
ski sarcoma viral oncogene homolog (avian) |
chr2_-_102731691 | 1.65 |
ENSMUST00000111192.3
ENSMUST00000111190.9 ENSMUST00000111198.9 ENSMUST00000111191.9 ENSMUST00000060516.14 ENSMUST00000099673.9 ENSMUST00000005218.15 ENSMUST00000111194.8 |
Cd44
|
CD44 antigen |
chr19_+_41471067 | 1.65 |
ENSMUST00000067795.13
|
Lcor
|
ligand dependent nuclear receptor corepressor |
chr16_-_4340920 | 1.65 |
ENSMUST00000090500.10
ENSMUST00000023161.8 |
Srl
|
sarcalumenin |
chr5_+_3393893 | 1.64 |
ENSMUST00000165117.8
ENSMUST00000197385.2 |
Cdk6
|
cyclin-dependent kinase 6 |
chr3_+_37694094 | 1.62 |
ENSMUST00000108109.8
ENSMUST00000038569.8 ENSMUST00000108107.2 |
Spry1
|
sprouty RTK signaling antagonist 1 |
chr9_-_116004265 | 1.61 |
ENSMUST00000061101.12
|
Tgfbr2
|
transforming growth factor, beta receptor II |
chr2_+_109747984 | 1.56 |
ENSMUST00000046548.14
ENSMUST00000111037.3 |
Lgr4
|
leucine-rich repeat-containing G protein-coupled receptor 4 |
chrX_+_159173680 | 1.56 |
ENSMUST00000112408.9
ENSMUST00000112402.8 ENSMUST00000112401.8 ENSMUST00000112400.8 ENSMUST00000112405.9 ENSMUST00000112404.9 ENSMUST00000146805.8 |
Adgrg2
|
adhesion G protein-coupled receptor G2 |
chr18_+_36414122 | 1.50 |
ENSMUST00000051301.6
|
Pura
|
purine rich element binding protein A |
chr4_-_123644091 | 1.49 |
ENSMUST00000102636.4
|
Akirin1
|
akirin 1 |
chr7_+_65511777 | 1.38 |
ENSMUST00000055576.12
ENSMUST00000098391.11 |
Pcsk6
|
proprotein convertase subtilisin/kexin type 6 |
chr4_+_99952988 | 1.38 |
ENSMUST00000039630.6
|
Ror1
|
receptor tyrosine kinase-like orphan receptor 1 |
chr4_-_82423985 | 1.30 |
ENSMUST00000107245.9
ENSMUST00000107246.2 |
Nfib
|
nuclear factor I/B |
chr5_-_50216249 | 1.29 |
ENSMUST00000030971.7
|
Adgra3
|
adhesion G protein-coupled receptor A3 |
chr13_-_99027544 | 1.26 |
ENSMUST00000109399.9
|
Tnpo1
|
transportin 1 |
chr15_+_80595486 | 1.25 |
ENSMUST00000067689.9
|
Tnrc6b
|
trinucleotide repeat containing 6b |
chr14_-_4808744 | 1.23 |
ENSMUST00000022303.17
ENSMUST00000091471.12 |
Thrb
|
thyroid hormone receptor beta |
chr6_-_71417607 | 1.23 |
ENSMUST00000002292.15
|
Rmnd5a
|
required for meiotic nuclear division 5 homolog A |
chr8_-_112603292 | 1.22 |
ENSMUST00000034431.3
|
Tmem170
|
transmembrane protein 170 |
chr10_-_102864904 | 1.20 |
ENSMUST00000167156.9
|
Alx1
|
ALX homeobox 1 |
chr13_+_5911481 | 1.20 |
ENSMUST00000000080.8
|
Klf6
|
Kruppel-like factor 6 |
chr9_-_43017249 | 1.12 |
ENSMUST00000165665.9
|
Arhgef12
|
Rho guanine nucleotide exchange factor (GEF) 12 |
chr7_-_119494918 | 1.11 |
ENSMUST00000059851.14
|
Dcun1d3
|
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
chr11_-_49603501 | 1.10 |
ENSMUST00000020624.7
ENSMUST00000145353.8 |
Cnot6
|
CCR4-NOT transcription complex, subunit 6 |
chr3_-_51184895 | 1.04 |
ENSMUST00000108051.8
ENSMUST00000108053.9 |
Elf2
|
E74-like factor 2 |
chr2_-_148250024 | 1.00 |
ENSMUST00000099270.5
|
Thbd
|
thrombomodulin |
chr6_+_14901343 | 0.95 |
ENSMUST00000115477.8
|
Foxp2
|
forkhead box P2 |
chr16_-_46317318 | 0.94 |
ENSMUST00000023335.13
ENSMUST00000023334.15 |
Nectin3
|
nectin cell adhesion molecule 3 |
chr18_+_56565188 | 0.88 |
ENSMUST00000070166.6
|
Gramd3
|
GRAM domain containing 3 |
chr3_+_137770813 | 0.87 |
ENSMUST00000163080.3
|
1110002E22Rik
|
RIKEN cDNA 1110002E22 gene |
chr11_-_118977047 | 0.87 |
ENSMUST00000026665.8
|
Cbx4
|
chromobox 4 |
chr3_+_128993568 | 0.85 |
ENSMUST00000029657.16
ENSMUST00000106382.11 |
Pitx2
|
paired-like homeodomain transcription factor 2 |
chr14_-_21102487 | 0.84 |
ENSMUST00000154460.8
ENSMUST00000130291.8 |
Ap3m1
|
adaptor-related protein complex 3, mu 1 subunit |
chr2_-_126718129 | 0.84 |
ENSMUST00000103224.10
|
Trpm7
|
transient receptor potential cation channel, subfamily M, member 7 |
chrX_+_158038778 | 0.84 |
ENSMUST00000126686.8
ENSMUST00000033671.13 |
Rps6ka3
|
ribosomal protein S6 kinase polypeptide 3 |
chr3_-_89820451 | 0.82 |
ENSMUST00000029559.7
ENSMUST00000197679.5 |
Il6ra
|
interleukin 6 receptor, alpha |
chr13_-_85437118 | 0.81 |
ENSMUST00000109552.3
|
Rasa1
|
RAS p21 protein activator 1 |
chr2_-_168048795 | 0.80 |
ENSMUST00000057793.11
|
Adnp
|
activity-dependent neuroprotective protein |
chr1_-_178165223 | 0.78 |
ENSMUST00000037748.9
|
Hnrnpu
|
heterogeneous nuclear ribonucleoprotein U |
chr13_-_115238427 | 0.76 |
ENSMUST00000224997.2
ENSMUST00000061673.9 |
Gm49395
Itga1
|
predicted gene, 49395 integrin alpha 1 |
chr17_-_63806963 | 0.75 |
ENSMUST00000024761.13
|
Fbxl17
|
F-box and leucine-rich repeat protein 17 |
chr9_+_109704609 | 0.75 |
ENSMUST00000094324.8
|
Cdc25a
|
cell division cycle 25A |
chr4_+_43875524 | 0.74 |
ENSMUST00000030198.7
|
Reck
|
reversion-inducing-cysteine-rich protein with kazal motifs |
chr6_-_129484070 | 0.72 |
ENSMUST00000183258.8
ENSMUST00000182784.4 ENSMUST00000032265.13 ENSMUST00000162815.2 |
Olr1
|
oxidized low density lipoprotein (lectin-like) receptor 1 |
chr2_+_79465696 | 0.72 |
ENSMUST00000111785.9
|
Itprid2
|
ITPR interacting domain containing 2 |
chr17_-_84495364 | 0.71 |
ENSMUST00000060366.7
|
Zfp36l2
|
zinc finger protein 36, C3H type-like 2 |
chr10_+_53473032 | 0.68 |
ENSMUST00000020004.8
|
Asf1a
|
anti-silencing function 1A histone chaperone |
chr6_+_66873381 | 0.65 |
ENSMUST00000043148.13
ENSMUST00000114228.8 ENSMUST00000114227.8 ENSMUST00000114226.8 ENSMUST00000204511.3 ENSMUST00000114225.8 ENSMUST00000114224.8 ENSMUST00000114222.4 |
Gng12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr19_-_29783389 | 0.65 |
ENSMUST00000177155.8
|
9930021J03Rik
|
RIKEN cDNA 9930021J03 gene |
chr6_-_126143678 | 0.61 |
ENSMUST00000112244.8
|
Ntf3
|
neurotrophin 3 |
chr17_-_88372671 | 0.59 |
ENSMUST00000235112.2
ENSMUST00000005504.15 |
Fbxo11
|
F-box protein 11 |
chr11_-_100830183 | 0.59 |
ENSMUST00000092671.12
ENSMUST00000103114.8 |
Stat3
|
signal transducer and activator of transcription 3 |
chr2_+_24257576 | 0.58 |
ENSMUST00000140547.2
ENSMUST00000102942.8 |
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr7_-_115637970 | 0.58 |
ENSMUST00000166877.8
|
Sox6
|
SRY (sex determining region Y)-box 6 |
chr5_+_147367237 | 0.57 |
ENSMUST00000176600.8
|
Pan3
|
PAN3 poly(A) specific ribonuclease subunit |
chr14_+_49303952 | 0.56 |
ENSMUST00000037473.6
ENSMUST00000228238.2 |
Ap5m1
|
adaptor-related protein complex 5, mu 1 subunit |
chr5_-_4154681 | 0.56 |
ENSMUST00000001507.5
|
Cyp51
|
cytochrome P450, family 51 |
chr3_+_97920819 | 0.55 |
ENSMUST00000079812.8
|
Notch2
|
notch 2 |
chr2_+_153583194 | 0.53 |
ENSMUST00000028981.9
|
Mapre1
|
microtubule-associated protein, RP/EB family, member 1 |
chr19_-_6107766 | 0.51 |
ENSMUST00000235520.2
ENSMUST00000007482.8 |
Mrpl49
|
mitochondrial ribosomal protein L49 |
chr2_-_12306722 | 0.51 |
ENSMUST00000028106.11
|
Itga8
|
integrin alpha 8 |
chrM_+_3906 | 0.47 |
ENSMUST00000082396.1
|
mt-Nd2
|
mitochondrially encoded NADH dehydrogenase 2 |
chr15_+_102378966 | 0.46 |
ENSMUST00000077037.13
ENSMUST00000229102.2 ENSMUST00000229618.2 ENSMUST00000229275.2 ENSMUST00000231089.2 ENSMUST00000229802.2 ENSMUST00000229854.2 ENSMUST00000108838.5 |
Pcbp2
|
poly(rC) binding protein 2 |
chr3_-_37286714 | 0.45 |
ENSMUST00000161015.2
ENSMUST00000029273.8 |
Il21
|
interleukin 21 |
chr16_+_11140740 | 0.43 |
ENSMUST00000180792.8
|
Snx29
|
sorting nexin 29 |
chr11_+_79883885 | 0.43 |
ENSMUST00000163272.2
ENSMUST00000017692.15 |
Suz12
|
SUZ12 polycomb repressive complex 2 subunit |
chr12_+_9624437 | 0.43 |
ENSMUST00000057021.9
|
Osr1
|
odd-skipped related transcription factor 1 |
chr6_-_99243455 | 0.41 |
ENSMUST00000113326.9
|
Foxp1
|
forkhead box P1 |
chr10_+_67815395 | 0.41 |
ENSMUST00000118160.8
|
Rtkn2
|
rhotekin 2 |
chr1_-_106641940 | 0.39 |
ENSMUST00000112751.2
|
Bcl2
|
B cell leukemia/lymphoma 2 |
chr5_+_16758777 | 0.39 |
ENSMUST00000030683.8
|
Hgf
|
hepatocyte growth factor |
chr1_+_59802543 | 0.35 |
ENSMUST00000087435.7
|
Bmpr2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
chr9_+_51958453 | 0.35 |
ENSMUST00000163153.9
|
Rdx
|
radixin |
chr4_+_125997734 | 0.33 |
ENSMUST00000116286.9
ENSMUST00000094761.11 |
Stk40
|
serine/threonine kinase 40 |
chr8_-_86281946 | 0.32 |
ENSMUST00000034138.7
|
Dnaja2
|
DnaJ heat shock protein family (Hsp40) member A2 |
chr3_-_9675130 | 0.32 |
ENSMUST00000041124.13
|
Zfp704
|
zinc finger protein 704 |
chr2_+_48704121 | 0.30 |
ENSMUST00000063886.4
|
Acvr2a
|
activin receptor IIA |
chr10_+_42637479 | 0.29 |
ENSMUST00000019937.5
|
Sec63
|
SEC63-like (S. cerevisiae) |
chr6_+_134807097 | 0.29 |
ENSMUST00000046303.12
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr4_-_133695204 | 0.26 |
ENSMUST00000100472.10
ENSMUST00000136327.2 |
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chr3_-_41037427 | 0.25 |
ENSMUST00000058578.8
|
Pgrmc2
|
progesterone receptor membrane component 2 |
chr4_+_89055359 | 0.25 |
ENSMUST00000058030.10
|
Mtap
|
methylthioadenosine phosphorylase |
chr1_-_161616031 | 0.24 |
ENSMUST00000000834.4
|
Fasl
|
Fas ligand (TNF superfamily, member 6) |
chr6_-_86503178 | 0.21 |
ENSMUST00000053015.7
|
Pcbp1
|
poly(rC) binding protein 1 |
chr5_+_123280250 | 0.18 |
ENSMUST00000174836.8
ENSMUST00000163030.9 |
Setd1b
|
SET domain containing 1B |
chr8_+_108020092 | 0.18 |
ENSMUST00000169453.8
|
Nfat5
|
nuclear factor of activated T cells 5 |
chrX_+_159945740 | 0.17 |
ENSMUST00000074802.12
ENSMUST00000019101.11 ENSMUST00000112345.8 |
Scml2
|
Scm polycomb group protein like 2 |
chr10_-_18891095 | 0.17 |
ENSMUST00000019997.11
|
Tnfaip3
|
tumor necrosis factor, alpha-induced protein 3 |
chr2_+_173501553 | 0.17 |
ENSMUST00000029024.10
ENSMUST00000109110.4 |
Rab22a
|
RAB22A, member RAS oncogene family |
chr8_+_107662352 | 0.17 |
ENSMUST00000212524.2
ENSMUST00000047425.5 |
Sntb2
|
syntrophin, basic 2 |
chr2_+_118731860 | 0.16 |
ENSMUST00000036578.7
|
Bahd1
|
bromo adjacent homology domain containing 1 |
chr5_+_122296322 | 0.16 |
ENSMUST00000102528.11
ENSMUST00000086294.11 |
Ppp1cc
|
protein phosphatase 1 catalytic subunit gamma |
chr1_+_74545203 | 0.14 |
ENSMUST00000087215.7
|
Cnot9
|
CCR4-NOT transcription complex, subunit 9 |
chr9_-_70564403 | 0.14 |
ENSMUST00000213380.2
ENSMUST00000049031.6 |
Mindy2
|
MINDY lysine 48 deubiquitinase 2 |
chr4_+_122889737 | 0.14 |
ENSMUST00000106252.9
|
Mycl
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
chr14_+_30741082 | 0.13 |
ENSMUST00000112098.11
ENSMUST00000112095.8 ENSMUST00000112106.8 ENSMUST00000146325.8 |
Pbrm1
|
polybromo 1 |
chr7_+_120276801 | 0.13 |
ENSMUST00000208454.2
ENSMUST00000060175.8 |
Mosmo
|
modulator of smoothened |
chr4_-_70453140 | 0.12 |
ENSMUST00000107359.9
|
Megf9
|
multiple EGF-like-domains 9 |
chr18_+_35904541 | 0.11 |
ENSMUST00000170693.9
ENSMUST00000237984.2 ENSMUST00000167406.2 |
Ube2d2a
|
ubiquitin-conjugating enzyme E2D 2A |
chr11_-_100541519 | 0.10 |
ENSMUST00000103119.10
|
Zfp385c
|
zinc finger protein 385C |
chr5_-_64126194 | 0.09 |
ENSMUST00000154169.4
|
Rell1
|
RELT-like 1 |
chr6_+_71470833 | 0.09 |
ENSMUST00000064637.11
ENSMUST00000114178.8 |
Rnf103
|
ring finger protein 103 |
chr3_+_151916059 | 0.09 |
ENSMUST00000166984.8
|
Fubp1
|
far upstream element (FUSE) binding protein 1 |
chr10_+_7556948 | 0.08 |
ENSMUST00000165952.9
|
Lats1
|
large tumor suppressor |
chr5_+_53713137 | 0.07 |
ENSMUST00000087360.9
|
Rbpj
|
recombination signal binding protein for immunoglobulin kappa J region |
chr17_+_29251602 | 0.07 |
ENSMUST00000130216.3
|
Srsf3
|
serine and arginine-rich splicing factor 3 |
chr5_-_92496730 | 0.06 |
ENSMUST00000038816.13
ENSMUST00000118006.3 |
Cxcl10
|
chemokine (C-X-C motif) ligand 10 |
chr4_-_138641225 | 0.06 |
ENSMUST00000097830.4
|
Otud3
|
OTU domain containing 3 |
chr4_-_141518202 | 0.04 |
ENSMUST00000038014.11
ENSMUST00000153880.2 |
Dnajc16
|
DnaJ heat shock protein family (Hsp40) member C16 |
chr17_+_26934617 | 0.04 |
ENSMUST00000062519.14
ENSMUST00000144221.2 ENSMUST00000142539.8 ENSMUST00000151681.2 |
Crebrf
|
CREB3 regulatory factor |
chr19_+_7394951 | 0.03 |
ENSMUST00000159348.3
|
2700081O15Rik
|
RIKEN cDNA 2700081O15 gene |
chr13_-_64300964 | 0.03 |
ENSMUST00000059817.12
ENSMUST00000117241.2 |
Zfp367
|
zinc finger protein 367 |
chr3_-_9898713 | 0.03 |
ENSMUST00000161949.8
|
Pag1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr9_-_123461593 | 0.03 |
ENSMUST00000026273.11
|
Slc6a20b
|
solute carrier family 6 (neurotransmitter transporter), member 20B |
chr8_-_35432783 | 0.02 |
ENSMUST00000033929.6
|
Tnks
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
1.0 | 6.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 3.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.7 | 2.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.7 | 2.9 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.7 | 3.4 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
0.6 | 2.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.5 | 2.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 1.6 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
0.5 | 1.6 | GO:0002649 | B cell tolerance induction(GO:0002514) regulation of tolerance induction to self antigen(GO:0002649) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.5 | 1.6 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.4 | 4.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 0.4 | GO:0061227 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.4 | 1.7 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 1.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 3.9 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.4 | 0.4 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.3 | 1.3 | GO:2000795 | lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 2.9 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.3 | 2.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 0.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 1.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.2 | 2.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 2.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 1.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 2.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 1.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.8 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.2 | 0.8 | GO:0060578 | subthalamic nucleus development(GO:0021763) superior vena cava morphogenesis(GO:0060578) |
0.2 | 3.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 2.6 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 4.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 3.1 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.7 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.8 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.5 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 1.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.1 | 2.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.6 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.4 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.1 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.4 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.1 | 0.3 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 1.0 | GO:2000794 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 1.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 2.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0034148 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.1 | 0.2 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.1 | 2.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 1.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 2.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.3 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.0 | 0.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.4 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.8 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.6 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 1.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 2.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 3.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.8 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 2.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.0 | 0.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 1.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.7 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 4.8 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 1.0 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 1.7 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 2.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.7 | 2.9 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.6 | 2.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.5 | 1.6 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.3 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
0.3 | 0.8 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.2 | 1.2 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 2.9 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 6.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 4.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 7.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 1.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 2.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 3.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 6.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 2.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 2.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 8.4 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.7 | 4.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.7 | 2.9 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.7 | 4.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 2.5 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.5 | 1.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.4 | 2.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.4 | 2.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 2.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 0.8 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.2 | 3.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 1.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 3.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 5.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 2.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 2.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 5.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 3.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 2.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.6 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 1.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.0 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 1.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 6.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 3.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 8.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 1.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 3.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 5.1 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.6 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 6.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.0 | 2.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 3.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 5.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 5.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 5.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 7.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 2.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 2.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 2.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 2.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 3.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 2.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 5.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 4.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 4.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 5.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 4.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 2.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |